$CNBX 8-K SEC Filings

Filed On	Filing
01 Oct 2026	8-K: Changes in Registrant's Certifying Accountant We have read the statements made by CNBX Pharmaceuticals Inc. under Item 4.01 of its Current Report on Form 8-K dated on or about October 1, 2026.
17 Mar 2026	8-K: Entry into a Material Definitive Agreement
30 Jan 2025	8-K: Entry into a Material Definitive Agreement
22 Mar 2024	8-K: Changes in Registrant's Certifying Accountant
08 Feb 2023	8-K: Departure/Election of Directors or Officers; Compensation
29 Dec 2022	8-K: Departure/Election of Directors or Officers; Compensation
25 Jul 2022	8-K: Departure/Election of Directors or Officers; Compensation
13 May 2022	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
28 Mar 2022	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events
16 Mar 2022	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
17 Feb 2022	8-K: Entry into a Material Definitive Agreement
19 Nov 2021	8-K: Departure/Election of Directors or Officers; Compensation
13 Sep 2021	8-K: Departure/Election of Directors or Officers; Compensation
19 Jul 2021	8-K: Departure/Election of Directors or Officers; Compensation
06 Jul 2021	8-K: Departure/Election of Directors or Officers; Compensation
28 Apr 2021	8-K: Entry into a Material Definitive Agreement; Temporary Suspension of Trading Under Employee Benefit Plans
21 Dec 2020	8-K: Entry into a Material Definitive Agreement
16 Nov 2020	8-K: Regulation FD Disclosure
02 Sep 2020	8-K: Departure/Election of Directors or Officers; Compensation
17 Apr 2020	8-K: Departure/Election of Directors or Officers; Compensation

Comments